Australia · Delayed Price · Currency is AUD Avecho Biotechnology Statistics
Total Valuation
ASX:AVE has a market cap or net worth of AUD 33.06 million. The enterprise value is 28.41 million.
| Market Cap | 33.06M |
| Enterprise Value | 28.41M |
Important Dates
The last earnings date was Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:AVE has 3.67 billion shares outstanding. The number of shares has increased by 1.05% in one year.
| Current Share Class | 3.67B |
| Shares Outstanding | 3.67B |
| Shares Change (YoY) | +1.05% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 23.24% |
| Owned by Institutions (%) | 0.01% |
| Float | 2.33B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.71 |
| PB Ratio | 21.20 |
| P/TBV Ratio | 21.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 29.97 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.43 |
| EV / Sales | 22.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.95, with a Debt / Equity ratio of 0.01.
| Current Ratio | 9.95 |
| Quick Ratio | 9.68 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.57 |
Financial Efficiency
Return on equity (ROE) is -182.91% and return on invested capital (ROIC) is -83.51%.
| Return on Equity (ROE) | -182.91% |
| Return on Assets (ROA) | -40.85% |
| Return on Invested Capital (ROIC) | -83.51% |
| Return on Capital Employed (ROCE) | -61.83% |
| Weighted Average Cost of Capital (WACC) | 10.65% |
| Revenue Per Employee | 82,517 |
| Profits Per Employee | -294,442 |
| Employee Count | 15 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 4.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.57% in the last 52 weeks. The beta is 0.96, so ASX:AVE's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +28.57% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 46.81 |
| Average Volume (20 Days) | 6,138,866 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:AVE had revenue of AUD 1.24 million and -4.42 million in losses. Loss per share was -0.00.
| Revenue | 1.24M |
| Gross Profit | 888,376 |
| Operating Income | -3.96M |
| Pretax Income | -4.42M |
| Net Income | -4.42M |
| EBITDA | -3.82M |
| EBIT | -3.96M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 4.66 million in cash and 14,473 in debt, with a net cash position of 4.65 million or 0.00 per share.
| Cash & Cash Equivalents | 4.66M |
| Total Debt | 14,473 |
| Net Cash | 4.65M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.56M |
| Book Value Per Share | 0.00 |
| Working Capital | 6.35M |
Cash Flow
| Operating Cash Flow | 1.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 71.77% |
| Operating Margin | -319.55% |
| Pretax Margin | -356.82% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:AVE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.05% |
| Shareholder Yield | -1.05% |
| Earnings Yield | -13.36% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |